Abbott Laboratories (BVMF:ABTT34)

Market Cap	1.27T
Revenue (ttm)	242.78B
Net Income (ttm)	77.12B
Shares Out	n/a
EPS (ttm)	44.16
PE Ratio	16.43
Forward PE	25.36
Dividend	0.73 (1.21%)
Ex-Dividend Date	Apr 14, 2025

Volume	73
Average Volume	1,812
Open	60.90
Previous Close	61.74
Day's Range	60.24 - 60.90
52-Week Range	45.81 - 67.65
Beta	0.74
RSI	39.56
Earnings Date	Jul 17, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: ABTT34

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD